World Orphan Drug Congress Europe 2022
14
Nov
-
17
Nov
2022
When
Sitges
Barcelona
Spain
Where

The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.

Similar Events

You May Like

Event

Terrapinn

0/5
(0)

Terrapinn events inspire and transform business.We’ve been sparking ideas, innovations and relationships that transform business for over 30 years. Using our global footprint, we bring innovators, disrupters and change agents together.

14 - 17 Nov 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Engagement Manager
Senior Director, Global Diagnostics / Newborn Screening
Managing Partner and co-founder
Clinical Advisor
Director, Therapeutic Policy and Advocacy
Scientific Director
Head of Market Access UK and Ireland
Chief Operating Officer
Co-Founder & Chief Executive Officer
Program Director
Chief Executive Officer
Head Public Affairs & Public Policy - Europe & Canada

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Worldwide Clinical Trials

Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way.

Pfizer

Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives.

Charles River Laboratories

At Charles River, we are passionate about our role in improving the quality of people’s lives.

Parexel

Parexel is focused on the development of innovative new therapies to improve the world’s health.

THREAD

THREAD’s platform helps unlock the power of your decentralized studies. Sponsors and CROs can remotely capture data from participants and sites during, in between and in lieu of in-clinic visits — securely through one unified platform.

Biogen

Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront

ICON plc

ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to pharmaceutical, biotechnology, medical device, and government and public health organisations.

IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry.

Pharma Business Partners

Pharma Business Partners is a consulting and market research firm focusing on the life sciences sector. Whilst our experience is global, we focus on MEA related work to add true insights and value to our clients portfolios.

Suvoda

Offering You Peace of Mind to Focus on Your Patients Suvoda’s sole focus is to offer the industry’s leading SaaS solution for randomization and trial supply management.

Caligor Coghlan Pharma Services

Since our founding, Caligor Coghlan Pharma Services has been striving to be the premier, global provider of pharma services. Our mission is to deliver high- quality services and access to life enhancing drugs for clients and patients worldwide.

Alexion Pharmaceuticals, Inc.

Our mission is to transform the lives of people living with rare diseases and devastating conditions through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services.

Charles River Associates

Charles River Associates (CRA) is a global consulting firm specializing in litigation, regulatory, financial, and management consulting.

Precision For Medicine

Precision is the first global precision medicine clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics.

Orphan Reach

A leading Contract Research Organization (CRO) designed to navigate the complexity of trials in orphan indications.

Aparito

Aparito is a global health tech company that brings clinical trials to patients and unlocks real-world data through mobile apps, video assessments & wearable devices.

Takeda

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society.

myTomorrows

myTomorrows is a platform that helps patients and physicians discover and access treatments in development.

Allucent

Allucent is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. The company is purpose-built through the convergence of leading providers to address this unmet need.

Ascenian

Optimized decision planning to accelerate patient access to health innovations.

Clinigen

Clinigen has more than 30 years’ experience providing quicker and broader access to critical medicines in 120+ countries, pre- and post-launch.

Organizer

Get emails from us

Thank you
Oops! Something went wrong